TY - JOUR
T1 - Association between specimen length and diagnostic yield of temporal artery biopsy
AU - Grossman, C.
AU - Ben-Zvi, I.
AU - Barshack, I.
AU - Bornstein, G.
N1 - Publisher Copyright:
© 2017 Informa Healthcare on license from Scandinavian Rheumatology Research Foundation.
PY - 2017/5/4
Y1 - 2017/5/4
N2 - Objectives: Temporal artery biopsy (TAB) is performed in patients suspected of giant cell arteritis (GCA). Inadequate TAB specimen length is considered a possible explanation for a negative biopsy in patients with GCA. We investigated the association between specimen length and diagnostic yield of TAB. Method: We conducted a retrospective analysis of 240 patients who underwent TAB in a single hospital between 2000 and 2015. Patients were diagnosed with GCA based on positive TAB or, when TAB was negative, on clinical grounds that fulfilled the American College of Rheumatology (ACR) 1990 criteria. Baseline clinical and laboratory features and TAB length were obtained from medical records. Among patients diagnosed with GCA, the rate of TAB positivity was calculated according to biopsy length (< 5, 5–9, 10–14, and ≥ 20 mm). Results: Out of 240 patients, 88 were diagnosed with GCA: 62 had a positive TAB and 26 were diagnosed based on clinical grounds despite a negative TAB. Among those who were diagnosed with GCA, the length of the TAB specimen was similar in those with a positive and a negative TAB (1.13 ± 1.68 mm vs. 1.15 ± 0.61 mm, respectively, p = 0.928). The TAB positivity rate was similar among all ranges of biopsy length [< 5 mm: 7/10 (70%); 5–9 mm: 22/31 (71%); 10–14 mm: 11/16 (69%); 15–19 mm: 11/16 (69%); ≥ 20 mm: 11/15 (73%, p = ns] and was similar to the overall biopsy positivity rate. Conclusions: Specimen length is not associated with diagnostic yield of TAB.
AB - Objectives: Temporal artery biopsy (TAB) is performed in patients suspected of giant cell arteritis (GCA). Inadequate TAB specimen length is considered a possible explanation for a negative biopsy in patients with GCA. We investigated the association between specimen length and diagnostic yield of TAB. Method: We conducted a retrospective analysis of 240 patients who underwent TAB in a single hospital between 2000 and 2015. Patients were diagnosed with GCA based on positive TAB or, when TAB was negative, on clinical grounds that fulfilled the American College of Rheumatology (ACR) 1990 criteria. Baseline clinical and laboratory features and TAB length were obtained from medical records. Among patients diagnosed with GCA, the rate of TAB positivity was calculated according to biopsy length (< 5, 5–9, 10–14, and ≥ 20 mm). Results: Out of 240 patients, 88 were diagnosed with GCA: 62 had a positive TAB and 26 were diagnosed based on clinical grounds despite a negative TAB. Among those who were diagnosed with GCA, the length of the TAB specimen was similar in those with a positive and a negative TAB (1.13 ± 1.68 mm vs. 1.15 ± 0.61 mm, respectively, p = 0.928). The TAB positivity rate was similar among all ranges of biopsy length [< 5 mm: 7/10 (70%); 5–9 mm: 22/31 (71%); 10–14 mm: 11/16 (69%); 15–19 mm: 11/16 (69%); ≥ 20 mm: 11/15 (73%, p = ns] and was similar to the overall biopsy positivity rate. Conclusions: Specimen length is not associated with diagnostic yield of TAB.
UR - http://www.scopus.com/inward/record.url?scp=84978998707&partnerID=8YFLogxK
U2 - 10.1080/03009742.2016.1196501
DO - 10.1080/03009742.2016.1196501
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 27440169
AN - SCOPUS:84978998707
SN - 0300-9742
VL - 46
SP - 222
EP - 225
JO - Scandinavian Journal of Rheumatology
JF - Scandinavian Journal of Rheumatology
IS - 3
ER -